Teva Pharmaceutical Q1 2024 Earnings Preview
https://seekingalpha.com/news/4101255-teva-pharmaceutical-q1-2024-earnings-preview?source=feed_tag_israel
May 07, 2024 - Teva Pharmaceutical is set to announce Q1 earnings results on May 8th.
0
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
https://www.zacks.com/stock/news/2268837/watch-these-5-drug-stocks-for-q1-earnings-beat-or-miss?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2268837
May 06, 2024 - Let us look at five drug, generic companies, PRGO, IOVA, VTRS, TEVA and ACAD, which are gearing up for their earnings release this week.
0
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held-by-drugmakers-including-for-ozempic.html
Apr 30, 2024 - The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others.
0
Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents
https://seekingalpha.com/news/4096525-novo-teva-astrazeneca-issued-ftc-warnings-over-bogus-patents?source=feed_sector_healthcare
Apr 30, 2024 - The FTC has sent warning letters to 10 drugmakers, including Novo Nordisk (NVO), Teva (TEVA) and AstraZeneca (AZN) over improper patent listings. Read more here.
0
Alvotech/Teva bring new partner to expand access for Humira biosimilar in U.S.
https://seekingalpha.com/news/4091382-alvotech-signs-u-s-agreement-to-expand-access-for-newly-approved-high-concentration?source=feed_sector_healthcare
Apr 19, 2024 - Alvotech (ALVO) in agreement with Teva Pharmaceuticals (TEVA), signed a long-term agreement with a strategic partner to further enhance access to Adalimumab-ryv in US market.
0
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
https://www.zacks.com/commentary/2257822/3-generic-drug-stocks-to-watch-amid-challenging-market-prospects?cid=CS-ZC-FT-industry_outlook-2257822
Apr 18, 2024 - The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to RDY, TEVA and VTRS.
0
Teva confirms efficacy in late-stage trial of its migraine treatment for adult Chinese patients
https://seekingalpha.com/news/4088897-teva-confirms-efficacy-in-late-stage-trial-of-its-migraine-treatment-for-adult-chinese-patients?source=feed_tag_israel
Apr 11, 2024 - Late-stage study confirms efficacy and safety of Teva Pharmaceutical's AJOVY in preventing migraines in adult Chinese patients.
0
Teva and mAbxience sign global licensing agreement for oncology biosimilar candidate
https://seekingalpha.com/news/4087243-teva-and-mabxience-sign-global-licensing-agreement-for-oncology-biosimilar-candidate?source=feed_tag_israel
Apr 04, 2024 - Teva Pharmaceuticals and mAbxience have signed a strategic licensing agreement to develop a biosimilar treatment for multiple oncology indications,...
0
Teva and Viatris revives chance to dispute J&J's schizophrenia drug patent
https://seekingalpha.com/news/4085739-teva-and-viatris-revives-chance-to-dispute-jjs-schizophrenia-drug-patent?source=feed_sector_healthcare
Apr 01, 2024 - Teva Pharmaceuticals and Viatris have been given a new opportunity to challenge the patent for Johnson and Johnson's schizophrenia drug in a U.S.
0
Teva stock trades in the green for seventh straight session
https://seekingalpha.com/news/4084589-teva-on-track-for-seventh-straight-day-of-gains?source=feed_tag_israel
Mar 27, 2024 - Teva Pharmaceutical (TEVA) shares are on the rise, gaining for the 7th consecutive day.
0
Page 1>